Skip to content

TANDARTSENGROEP BEUTELS

Active
Private limited companyfounded 200719 yrs activeKapelstraat 142, 3550 Heusden-Zolder, BelgiumKBO/BCE: BE 0888.820.403
Summary

TANDARTSENGROEP BEUTELS has been active since 2007 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.20M and a net result of €471k. Equity is growing by ~2.6% per year across the filed fiscal years. Its solvency ranks better than 63% of 2344 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).

Checked score

Score 2025
Axes · tick = 2024
Profitability100▲+5
Solvency99▲+13
Growth78▲+20
Track record100
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €110k at 30 days acceptable
Liquidity ample (current ratio 3.24 against 1.87 in 2024; short-term debt: 25.7% and cash: 20.6% of total assets), and 26.1% of the assets are financed with debt.
Credit check for your own amount and term

Signals

Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
73.9%
Return on assets
29.1%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 19 years 0 20 y
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-07-2026, 7 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
7 d early
2024
1 d early
2023
20 d early
2022
11 d early
2021
3 d early
2020
5 d early
2019
22 d early
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
25-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, abbreviated schema

Equity
€1.20M▲ 65.0%
2024 · €725k
2018: €954k 2019: €662k▼ -30.6% vs 2018 2020: €454k▼ -31.5% vs 2019 2021: €405k▼ -10.8% vs 2020lowest in 8 years 2022: €423k▲ +4.6% vs 2021 2023: €478k▲ +13.0% vs 2022 2024: €725k▲ +51.6% vs 2023 2025: €1.20M▲ +65.0% vs 2024highest in 8 years
2018 → 2025
Total assets
€1.62M▲ 35.5%
2024 · €1.19M
2018: €1.36M 2019: €1.26M▼ -7.0% vs 2018 2020: €1.11M▼ -11.6% vs 2019 2021: €951k▼ -14.6% vs 2020 2022: €912k▼ -4.1% vs 2021 2023: €894k▼ -1.9% vs 2022lowest in 8 years 2024: €1.19M▲ +33.6% vs 2023 2025: €1.62M▲ +35.5% vs 2024highest in 8 years
2018 → 2025
Net result
€471k▲ 90.8%
2024 · €247k
2018: €38k 2019: €-292k▼ -872% vs 2018lowest in 8 years 2020: €-209k▲ +28.5% vs 2019 2021: €-49k▲ +76.6% vs 2020 2022: €19k▲ +138% vs 2021 2023: €55k▲ +195% vs 2022 2024: €247k▲ +349% vs 2023 2025: €471k▲ +90.8% vs 2024highest in 8 years
2018 → 2025
Working capital
€933k▲ 133%
2024 · €401k
2018: €801k 2019: €20k▼ -97.5% vs 2018 2020: €67k▲ +238% vs 2019 2021: €-23k▼ -134% vs 2020lowest in 8 years 2022: €43k▲ +288% vs 2021 2023: €83k▲ +93.7% vs 2022 2024: €401k▲ +384% vs 2023 2025: €933k▲ +133% vs 2024highest in 8 years
2018 → 2025
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€405k-€423k▲ 4.6%€478k▲ 13.0%€725k▲ 51.6%€1.20M▲ 65.0% 2021: €405klowest in 5 years 2022: €423k▲ +4.6% vs 2021 2023: €478k▲ +13.0% vs 2022 2024: €725k▲ +51.6% vs 2023 2025: €1.20M▲ +65.0% vs 2024highest in 5 years
Operating result€-43k-€33k€69k▲ 111%€258k▲ 271%€487k▲ 88.9% 2021: €-43klowest in 5 years 2022: €33k▲ +176% vs 2021 2023: €69k▲ +111% vs 2022 2024: €258k▲ +271% vs 2023 2025: €487k▲ +88.9% vs 2024highest in 5 years
Net result€-49k-€19k€55k▲ 195%€247k▲ 349%€471k▲ 90.8% 2021: €-49klowest in 5 years 2022: €19k▲ +138% vs 2021 2023: €55k▲ +195% vs 2022 2024: €247k▲ +349% vs 2023 2025: €471k▲ +90.8% vs 2024highest in 5 years
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
€-200k€0€200k€400kOperating result 2021: €-43k€-43kNet result 2021: €-49k€-49kOperating result 2022: €33k€33kNet result 2022: €19k€19kOperating result 2023: €69k€69kNet result 2023: €55k€55kOperating result 2024: €258k€258kNet result 2024: €247k€247kOperating result 2025: €487k€487kNet result 2025: €471k€471k20212022202320242025€0€200k€400kOperating result 2023: €69k€69kNet result 2023: €55k€55kOperating result 2024: €258k€258kNet result 2024: €247k€247kOperating result 2025: €487k€487kNet result 2025: €471k€471k202320242025
The operating result has risen four years in a row; 2025 is 89% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.62M
Fixed assets €270k ▼ 18.6%
Current assets €1.35M ▲ 56.3%
Equity and liabilities €1.62M
Equity €1.20M ▲ 65.0%
Debt €422k ▼ 10.0%
Debt's share of the balance-sheet total falls from 39.3% to 26.1%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€568k▲
2024 · €347k
Cash flow
€552k▲
2024 · €336k
Current ratio
3.24▲
2024 · 1.87
Quick ratio
2.65▲
2024 · 1.46
Debt to equity
0.35▼
2024 · 0.65
ROE
39.4%▲
2024 · 34.0%
ROA
29.1%▲
2024 · 20.7%
Interest coverage
17.94▼
2024 · 18.61
Debt ≤ 1 year
€416k▼
2024 · €461k
Income taxes
€345▲
2024 · €292
Staff costs
€691k▲
2024 · €625k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 51 lines
Balance sheet Code20242025
Assets
Total assets20/58€1.19M€1.62M▲
Fixed assets21/28€332k€270k▼
Intangible fixed assets21€20k€15k▼
Tangible fixed assets22/27€312k€255k▼
Plant, machinery and equipment23€164k€143k▼
Furniture and vehicles24€12k€7k▼
Other tangible fixed assets26€136k€105k▼
Current assets29/58€862k€1.35M▲
Amounts receivable after more than one year29€50k€50k=
Other amounts receivable291€50k€50k=
Stocks and contracts in progress3€190k€246k▲
Stocks30/36€190k€246k▲
Amounts receivable within one year40/41€563k€683k▲
Trade receivables40€103k€103k▼
Other amounts receivable41€460k€581k▲
Cash at bank and in hand54/58€51k€334k▲
Deferred charges and accrued income490/1€9k€35k▲
Equity and liabilities
Total equity and liabilities10/49€1.19M€1.62M▲
Equity10/15€725k€1.20M▲
Contributions10/11€308k€308k=
Reserves13€410k€881k▲
Distributable reserves133€410k€881k▲
Profit (loss) carried forward14€7k€8k▲
Amounts payable17/49€469k€422k▼
Amounts payable within one year42/48€461k€416k▼
Trade debts44€388k€323k▼
Suppliers440/4€388k€323k▼
Advances received on contracts in progress46€12k€16k▲
Taxes, remuneration and social security45€62k€77k▲
Taxes450/3€4k€4k▲
Remuneration and social security454/9€58k€73k▲
Accrued charges and deferred income492/3€8k€6k▼
Income statement Code20242025
Remuneration, social security and pensions62€625k€691k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€89k€81k▼
Other operating charges640/8€18k€2k▼
Non-recurring operating charges66A-€30k
Gross operating margin9900€990k€1.29M▲
Operating profit (loss)9901€258k€487k▲
Financial income75/76B€8k€16k▲
Recurring financial income75€8k€16k▲
Financial charges65/66B€19k€32k▲
Recurring financial charges65€19k€32k▲
Profit (loss) for the period before taxes9903€247k€472k▲
Income taxes67/77€292€345▲
Profit (loss) for the period9904€247k€471k▲
Profit (loss) for the period to be appropriated9905€247k€471k▲
Appropriation of the result
Profit (loss) to be appropriated9906€252k€479k▲
Profit (loss) brought forward from the previous period14P€5k€7k▲
Transfer to equity691/2€245k€471k▲
To other reserves6921€245k€471k▲
Social balance
Average headcount (FTE)908712.914.7▲

The notes to these accounts (14 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Accounts by statement
Line20212022202320242025Change
Remuneration, social security and pensions62€361k€522k€588k€625k€691k▲ 10.6%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€114k€106k€106k€89k€81k▼ 9.7%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€0-----
Other operating charges640/8€11k€373€5k€18k€2k▼ 90.3%
Non-recurring operating charges66A----€30k-
Gross operating margin9900€443k€662k€769k€990k€1.29M▲ 30.4%
Operating profit (loss)9901€-43k€33k€69k€258k€487k▲ 88.9%
Financial income75/76B€6k€2k€229€8k€16k▲ 102%
Recurring financial income75€6k€2k€229€8k€16k▲ 102%
Financial charges65/66B€10k€15k€14k€19k€32k▲ 69.6%
Recurring financial charges65€10k€15k€14k€19k€32k▲ 69.6%
Profit (loss) for the period before taxes9903€-47k€19k€55k€247k€472k▲ 90.7%
Income taxes67/77€2k€576€339€292€345▲ 18.2%
Profit (loss) for the period9904€-49k€19k€55k€247k€471k▲ 90.8%
Profit (loss) for the period to be appropriated9905€-49k€19k€55k€247k€471k▲ 90.8%
Line20212022202320242025Change
Assets
Total assets20/58€951k€912k€894k€1.19M€1.62M▲ 35.5%
Fixed assets21/28€565k€512k€403k€332k€270k▼ 18.6%
Intangible fixed assets21€45k€36k€27k€20k€15k▼ 25.0%
Tangible fixed assets22/27€519k€476k€376k€312k€255k▼ 18.2%
Plant, machinery and equipment23€263k€258k€200k€164k€143k▼ 13.0%
Furniture and vehicles24€27k€22k€11k€12k€7k▼ 37.9%
Other tangible fixed assets26€230k€196k€165k€136k€105k▼ 22.8%
Current assets29/58€386k€400k€491k€862k€1.35M▲ 56.3%
Amounts receivable after more than one year29--€50k€50k€50k=
Other amounts receivable291--€50k€50k€50k=
Stocks and contracts in progress3€123k€146k€192k€190k€246k▲ 29.7%
Stocks30/36€123k€146k€192k€190k€246k▲ 29.7%
Amounts receivable within one year40/41€121k€84k€125k€563k€683k▲ 21.4%
Trade receivables40€119k€81k€103k€103k€103k▼ 0.4%
Other amounts receivable41€3k€3k€22k€460k€581k▲ 26.2%
Cash at bank and in hand54/58€139k€144k€114k€51k€334k▲ 557%
Deferred charges and accrued income490/1€2k€27k€11k€9k€35k▲ 301%
Equity and liabilities
Total equity and liabilities10/49€951k€912k€894k€1.19M€1.62M▲ 35.5%
Equity10/15€405k€423k€478k€725k€1.20M▲ 65.0%
Contributions10/11€308k€308k€308k€308k€308k=
Reserves13€95k€113k€165k€410k€881k▲ 115%
Distributable reserves133€95k€113k€165k€410k€881k▲ 115%
Profit (loss) carried forward14€2k€2k€5k€7k€8k▲ 2.3%
Amounts payable17/49€546k€489k€416k€469k€422k▼ 10.0%
Amounts payable after more than one year17€120k€120k€0---
Other amounts payable178/9€120k€120k€0---
Amounts payable within one year42/48€409k€357k€408k€461k€416k▼ 9.9%
Trade debts44€308k€229k€332k€388k€323k▼ 16.7%
Suppliers440/4€308k€229k€332k€388k€323k▼ 16.7%
Advances received on contracts in progress46€8k€3k€8k€12k€16k▲ 29.5%
Taxes, remuneration and social security45€68k€97k€68k€62k€77k▲ 24.6%
Taxes450/3€5k€7k€4k€4k€4k▲ 11.7%
Remuneration and social security454/9€62k€89k€65k€58k€73k▲ 25.4%
Other amounts payable47/48€26k€28k€0---
Accrued charges and deferred income492/3€17k€11k€8k€8k€6k▼ 16.2%
Line20212022202320242025Change
Profit (loss) for the period9904€-49k€19k€55k€247k€471k▲ 90.8%
+ Depreciation and write-downs630€114k€106k€106k€89k€81k▼ 9.7%
Operating cash flow (approximation)€65k€124k€161k€336k€552k▲ 64.1%
Investment in fixed assets (approximation)-€-53k€2k€-18k€-19k▼ 3.1%
Change in cash-€4k€-30k€-63k€283k▲ 552%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Sign in to download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
24-07
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial Highest result since 2018net €471k ▲90.8%
Operating result €487k, net result €471k, both a record.
31-12
Financial Equity above €1MEq €1.20M ▲65%
4 profitable years in a row build equity to €1.20M.
30-07
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
08-07
State Gazette act Appointment: Moore Audit (statutory auditor)
Permanent representative: Sam Kwanten · Power of attorney4 facts ▸
  • General meeting, 24-06-2024
  • Auditor appointment, Moore Audit (statutory auditor)
  • Permanent representative, Sam Kwanten
  • Power of attorney, Colosseum Dental België
2024
31-12
Financial Equity above €500kEq €725k ▲51.6%
3 profitable years in a row build equity to €725k.
11-07
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
24-11
State Gazette act Permanent representative: Jarkko Jokinen
Resignation: Patrick Bakker (permanent representative)3 facts ▸
  • Board meeting, 23-10-2023
  • Permanent representative, Jarkko Jokinen
  • Director resignation, Patrick Bakker (permanent representative)
20-07
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
25-04
State Gazette act Appointments: Moore Audit (statutory auditor) and Colosseum Dental België (bijkomende b bestuurder)
Resignations: Patrick Bakker (director) and Maarten ter Haar (director) · Permanent representative: Patrick Bakker7 facts ▸
  • General meeting, 27-06-2022
  • Auditor appointment, Moore Audit (statutory auditor)
  • General meeting, 16-01-2023
  • Director resignation, Patrick Bakker (director)
  • Director resignation, Maarten ter Haar (director)
  • Director appointment, Colosseum Dental België (bijkomende b bestuurder)
  • Permanent representative, Patrick Bakker
2022
31-12
Financial Back to profitnet €19k
Net result €19k after 3 loss-making years.
30-08
State Gazette act Resignations: Raoul Francis Dias (director) and Daniel Fehr (director)
3 facts ▸
  • General meeting, 29-07-2022
  • Director resignation, Raoul Francis Dias (director)
  • Director resignation, Daniel Fehr (director)
Show earlier events
28-07
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
28-02
State Gazette act Appointments: Maarten ter Haar (director) and Patrick Bakker (director)
3 facts ▸
  • General meeting, 21-01-2022
  • Director appointment, Maarten ter Haar (director)
  • Director appointment, Patrick Bakker (director)
13-01
State Gazette act Resignation: Dentconnect België BV (director)
Appointments: Daniel Fehr (class B director) and Raoul Dias (class B director)4 facts ▸
  • General meeting, 25-11-2021
  • Director resignation, Dentconnect België BV (director)
  • Director appointment, Daniel Fehr (class B director)
  • Director appointment, Raoul Dias (class B director)
2021
08-11
State Gazette act Resignation: Prophylaxis Participations B.V. (director)
Permanent representative: Chris Cools · Director discharge4 facts ▸
  • General meeting, 12-10-2021
  • Director resignation, Prophylaxis Participations B.V. (director)
  • Permanent representative, Chris Cools
  • Director discharge, Prophylaxis Participations B.V.
26-07
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
09-07
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema
24-01
State Gazette act Reappointment: PKF-VMB Bedrijfsrevisoren (statutory auditor)
Resignations: Bart VAN DER AUWELAER (director) and CRSG België B.V. (director) · Appointments: Dentconnect België (director) and Curaeos B.V. (director) · Permanent representatives: Jeroen VAN DER HAMSVOORT and Chris COOLS11 facts ▸
  • General meeting, 03-06-2019
  • Auditor reappointment, PKF-VMB Bedrijfsrevisoren
  • General meeting, 11-12-2019
  • Director resignation, Bart VAN DER AUWELAER (director)
  • Director resignation, CRSG België B.V. (director)
  • Director appointment, Dentconnect België (director)
  • Permanent representative, Jeroen VAN DER HAMSVOORT
  • Director appointment, Curaeos B.V. (director)
  • Permanent representative, Chris COOLS
  • Mandate compensation, Dentconnect België
  • Mandate compensation, Curaeos B.V.
2019
31-12
Financial Weakest financial yearnet €-292k
Net result drops to €-292k, the lowest in the series; recovery starts the following year.
30-07
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
24-07
State Gazette act Permanent representative: Bart Borms
Legal-form conversion · Reserve release · Share split10 facts ▸
  • General meeting, 08-07-2019
  • Legal-form conversion, Besloten vennootschap met beperkte aansprakelijkheid (opt-in)
  • Reserve release, Omvorming van statutair onbeschikbare eigen vermogensrekening in beschikbare eigen vermogensrekening
  • Share split, 500, splitsing
  • Statutes amendment
  • Board composition, Marina Beutels (bestuurder a)
  • Board composition, Hendrik Claes (bestuurder a)
  • Board composition, Bart van der Auwelaer (bestuurder b)
  • Board composition, CRSG België BVBA (bestuurder b)
  • Permanent representative, Bart Borms
16-05
State Gazette act Registered office
Registered-office move2 facts ▸
  • Board meeting, 27-03-2019
  • Registered-office move, 3550 Heusden-Zolder, Kapelstraat 142
12-02
State Gazette act Resignation: Jacob Vermeule (zaakvoerder type b)
Appointment: CRSG België B.V. (zaakvoerder type b) · Permanent representative: Bart Borms · Power of attorney5 facts ▸
  • General meeting, 29-11-2018
  • Director resignation, Jacob Vermeule (zaakvoerder type b)
  • Director appointment, CRSG België B.V. (zaakvoerder type b)
  • Permanent representative, Bart Borms
  • Power of attorney, Allen & Overy LLP
2018
10-12
State Gazette act Resignation: Jerry George (zaakvoerder type b)
Power of attorney3 facts ▸
  • General meeting, 01-11-2018
  • Director resignation, Jerry George (zaakvoerder type b)
  • Power of attorney, Allen & Overy LLP
31-08
NBB filing Annual accounts filed
fiscal year 2017 · full schema · 31 days late
17-01
State Gazette act Appointment: Van der Auwelaer Bart (zaakvoerder type b)
Purpose change · Mandate compensation · Statutes amendment7 facts ▸
  • General meeting, 14-12-2017
  • Purpose change, De vennootschap heeft tot doel in België en in het buitenland, uitsluitend in eigen naam en voor eigen rekening: a)het opzetten en exploiteren van voorzieningen…
  • Director appointment, Van der Auwelaer Bart (zaakvoerder type b)
  • Mandate compensation, Van der Auwelaer Bart
  • Statutes amendment
  • Capital, €280.000
  • Power of attorney, VANDELANOTTE H-L
2017
29-08
NBB filing Annual accounts filed
fiscal year 2016 · full schema · 29 days late
03-07
State Gazette act Appointment: PKF-VMB Bedrijfsrevisoren BVCVBA (statutory auditor)
Permanent representative: Luc Martens3 facts ▸
  • General meeting, 10-05-2017
  • Auditor appointment, PKF-VMB Bedrijfsrevisoren BVCVBA (statutory auditor)
  • Permanent representative, Luc Martens
2016
17-11
State Gazette act Resignation: Johannes Kruijtzer (zaakvoerder b)
Appointment: Jerry George (zaakvoerder b) · Mandate compensation4 facts ▸
  • General meeting, 24-10-2016
  • Director resignation, Johannes Kruijtzer (zaakvoerder b)
  • Director appointment, Jerry George (zaakvoerder b)
  • Mandate compensation, Jerry George
05-08
State Gazette act Appointments: Hendrik Claes, Johannes Kruijtzer and 2 others
Mandate compensation8 facts ▸
  • General meeting, 16-06-2016
  • Director appointment, Hendrik Claes (zaakvoerder a)
  • Director appointment, Johannes Kruijtzer (zaakvoerder b)
  • Director appointment, Jacob Vermeule (zaakvoerder b)
  • Mandate compensation, Hendrik Claes
  • Mandate compensation, Johannes Kruijtzer
  • Mandate compensation, Jacob Vermeule
  • Director appointment, Marina Beutels (zaakvoerder a)
01-07
State Gazette act Statutes amendment
Power of attorney3 facts ▸
  • General meeting, 16-06-2016
  • Statutes amendment
  • Power of attorney, ALTIUS burg. CVBA
11-05
State Gazette act Purpose · Statutes amendment
Purpose change · Power of attorney · Manager report8 facts ▸
  • General meeting, 27-04-2016
  • Purpose change, De vennootschap heeft tot doel: - de inrichting en de uitbating van één of meerdere tandartspraktijken en het faciliteren van de uitoefening van de tandheelkund…
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
  • Power of attorney, VANDERMAESEN ROSETTE
  • Manager report, 25-04-2016
  • Summary balance sheet, 31-03-2016
2014
24-03
State Gazette act Capital & shares
Capital increase · Bank account · Capital5 facts ▸
  • General meeting, 24-12-2013
  • Capital increase, €255.000
  • Bank account, RECORD Bank, 652-9571347-51
  • Capital, €280.000
  • Statutes amendment
2013
14-05
State Gazette act Capital & shares
Capital decrease · Capital · Statutes amendment5 facts ▸
  • General meeting, 29-04-2013
  • Capital decrease, €100.000
  • Capital, €25.000
  • Statutes amendment
  • Power of attorney, zaakvoerder
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
20 of 21 acts read
About the unread acts

Of the 21 Belgian State Gazette acts we know for this company, 20 have been read. The other one has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
6 directors, last change in 2022
Raoul Dias
Class B director · since 25-11-2021
Current
Colosseum Dental België
Bijkomende b bestuurder · since 30-09-2019 · Private limited company · perm. rep.: Patrick Bakker
Current
Curaeos B.V.
Director · since 30-09-2019 · Legal entity · perm. rep.: Chris COOLS
Not recently confirmed
Van der Auwelaer, Bart
Zaakvoerder type b · since 14-12-2017
Not recently confirmed
Hendrik Claes
Zaakvoerder a · since 16-06-2016
Not recently confirmed
Marina Beutels
Zaakvoerder a · since 16-06-2016
Not recently confirmed
01-09-2022 Colosseum Dental België: Appointed as Bijkomende b bestuurder
01-09-2022 Maarten ter Haar: Resigned as Director
01-09-2022 Patrick Bakker: Resigned as Director
29-07-2022 Daniel Fehr: Resigned as Director
29-07-2022 Raoul Francis Dias: Resigned as Director
Full history in the Timeline (25 changes) →
Not every act has been read: a resignation may be missing here
1 of this company's 21 Belgian State Gazette acts has not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Heusden-Zolder · 1 establishment unit since 2007
seat establishment The establishment unit on the map
Ground area
4,881 m²
Building footprint
773 m²
Volume, LiDAR
4,936 m³
Parcel 71025A2000/00R002, Flanders · tallest building 10.6 m, ±2 floors. Linked by address, not a title deed.
9 companies at this address See who is registered here
1 establishment unit
Kapelstraat 142, 3550 Heusden-Zolder
NACE 85130
since 20072.229.356.443
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
71025A2000/00R002 Flanders 4,881 m² 1 · 773 m² 10.6 m · 2 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Statutory auditor

1 auditor
Moore AuditCurrent
Statutory auditor · represented by Sam Kwanten
27-06-2022 → present
Show 1 earlier auditors
PKF-VMB Bedrijfsrevisoren
Auditor
succeeded by Moore Audit in 2022
03-06-2019 → 27-06-2022

Articles of association

Who signs
“Indien er twee of meer zaakvoerders worden benoemd, dan wordt de vennootschap jegens derden als eiser of als verweerder rechtsgeldig vertegenwoordigd door: - hetzij een zaakvoerder-B, alleen handelend; - hetzij een zaakvoerder-A, gezamenlijk handelend met een zaakvoerder-B.”
Purpose
Het opzetten en exploiteren van voorzieningen en organisaties voor de gezondheidszorg waarin medische specialisten onderzoeken en/of behandelingen in het domein van de…
Full purpose

Het opzetten en exploiteren van voorzieningen en organisaties voor de gezondheidszorg waarin medische specialisten onderzoeken en/of behandelingen in het domein van de tandheelkunde hun activiteiten kunnen verrichten; het mogelijk maken van het uitoefenen van een tandartsenpraktijk; de opzetting en de exploitatie van een tandheelkundige praktijk, orthodontie, dentofaciale orthopedie; het aanleggen, het oordeelkundig uitbouwen en beheren van een onroerend vermogen; het aanleggen, het oordeelkundig uitbouwen en beheren van een roerend vermogen; het aangaan en verstrekken van leningen, kredieten, financieringen en het aangaan van leasingcontracten.

Structure & network

Connections & network

5 connected companies
Depth
This company Company Director Shareholding Click a node to look further, drag to arrange, scroll to zoom.
Linked via shared directors
Aldental
Shared director
→
ConsTand
Shared director
→
→
→
Show 1 more companies with a shared director
TANDHEELKUNDIG CENTRUM
Shared director
→

Capital and shareholders

Shareholders according to the acts
After the capital increase act of 24-03-2014 ↗
  • BEUTELS Marina Maria

The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years
  1. 17-01-2018 Capital stated in the act · 280,000 EUR · 125 shares
  2. 24-03-2014 Capital increase of 255,000 EUR · to 280,000 EUR · in cash
  3. 14-05-2013 Capital reduction of 100,000 EUR · to 25,000 EUR · repaid to the shareholders

Similar companies · same sector, comparable size

Of 6,942 companies in sector 86230 we hold annual accounts for 4,293. 2,708 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded17-04-2007
Fiscal year end31-12
Activities, NACEBEL 2025
86230Dental practice
Contact
E-mail tandartsen@beutels.beHeusden-Zolder
Phone 011.57.13.38Heusden-Zolder

Scores and ratios are computed by Checked and are not a credit decision.